A European prospective observational study to evaluate fracture outcomes, back pain, health-related quality of life, and compliance in patients with osteoporosis during and after treatment with Forsteo

Trial Profile

A European prospective observational study to evaluate fracture outcomes, back pain, health-related quality of life, and compliance in patients with osteoporosis during and after treatment with Forsteo

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2017

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Osteoporosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ExFOS
  • Most Recent Events

    • 08 Jul 2017 New trial record
    • 01 Aug 2014 Study design and baseline characteristics of participants of the Extended Forsteo Observational Study (ExFOS), published in the Current Medical Research and Opinion Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top